About OpSens
OpSens is a company based in Quebec City (Canada) founded in 2003 was acquired by Haemonetics in October 2023. The company has 18 employees as of December 31, 2019. OpSens offers products and services including FFR Pressure Guidewire and Fiber Optic Sensing Solutions. OpSens operates in a competitive market with competitors including Innoviz, LeddarTech, UTStar, Datagration and Contego Medical, among others.
- Headquarter Quebec City, Canada
- Employees 18 as on 31 Dec, 2019
- Stage Public
-
Sectors
Energy & UtilitiesHealthcare Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Opsens Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Haemonetics
& 3 more
-
Employee Count
18
as on Dec 31, 2019
-
Acquired by
Haemonetics
(Oct 10, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OpSens
OpSens offers a comprehensive portfolio of products and services, including FFR Pressure Guidewire and Fiber Optic Sensing Solutions.
Advanced guidewire for measuring fractional flow reserve in cardiac procedures
Innovative systems for monitoring pressure and temperature in oil and gas industries
Funding Insights of OpSens
Investors in OpSens
OpSens has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Haemonetics, National Research Council Canada and CDTI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Locked | Locked | Locked | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Locked | Locked | Locked | |
|
Government-backed foundation focused on technological development
|
Locked | Locked | Locked |
Investor details for OpSens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OpSens
Investment portfolio details for OpSens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OpSens
Detailed financials for OpSens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opsens Comparisons
Peer comparison for OpSens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OpSens
OpSens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Innoviz, LeddarTech, UTStar, Datagration and Contego Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of solid-state LiDAR sensors and perception software for autonomous vehicles
|
|
| Locked | Locked | Locked |
Developer of raw data fusion and perception software for automotive ADAS/AD
|
|
| Locked | Locked | Locked |
Enterprise networking management solutions provider
|
|
| Locked | Locked | Locked |
AI-driven analytics solutions are provided for oil and gas companies.
|
|
| Locked | Locked | Locked |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| Locked | Locked | Locked |
Smart devices for monitoring coronary artery disease are developed.
|
Detailed competitors of OpSens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opsens
Complete news archive for OpSens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OpSens
OpSens was founded in 2003 and raised its 1st funding round 5 years after it was founded.
OpSens is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Christopher Simon is the current CEO of OpSens.
As of Dec 31, 2019, the latest employee count at OpSens is 18.
Optical sensors are designed and developed by OpSens, founded in 2003 and based in Quebec City, Canada. These sensors are applied in the oil and gas industry for measurements in harsh environments, including temperature, pressure, strain, and deformation. In healthcare, focus is placed on interventional cardiology applications. Signal conditioners are also provided to support these operations across relevant sectors.
OpSens's top competitors include Innoviz, LeddarTech and Contego Medical.
OpSens offers FFR Pressure Guidewire and Fiber Optic Sensing Solutions.
OpSens has 4 investors. Key investors include Haemonetics, National Research Council Canada, CDTI, and Lumira Ventures.